Beiersdorf Aktiengesellschaft (OTCMKTS:BDRFF) Stock Price Up 0.7% – Should You Buy?

Shares of Beiersdorf Aktiengesellschaft (OTCMKTS:BDRFF) rose 0.7% during mid-day trading on Wednesday . The stock traded as high as $81.0750 and last traded at $81.0750. Approximately 1,824 shares traded hands during trading, a decline of 65% from the average daily volume of 5,226 shares. The stock had previously closed at $80.54.

Analyst Upgrades and Downgrades

BDRFF has been the subject of several research reports. JPMorgan Chase & Co. reissued a “neutral” rating on shares of Beiersdorf Aktiengesellschaft in a research report on Wednesday, March 18th. Morgan Stanley downgraded shares of Beiersdorf Aktiengesellschaft from an “equal weight” rating to an “underweight” rating in a research report on Monday, March 16th. Royal Bank Of Canada downgraded shares of Beiersdorf Aktiengesellschaft from a “sector perform” rating to an “underperform” rating in a research report on Tuesday, March 10th. Berenberg Bank reaffirmed a “hold” rating on shares of Beiersdorf Aktiengesellschaft in a research report on Monday, March 23rd. Finally, UBS Group raised shares of Beiersdorf Aktiengesellschaft from a “sell” rating to a “neutral” rating in a research report on Tuesday, March 31st. Four research analysts have rated the stock with a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Reduce”.

Beiersdorf Aktiengesellschaft Price Performance

The business’s 50-day moving average is $84.72 and its two-hundred day moving average is $98.61.

About Beiersdorf Aktiengesellschaft

Beiersdorf Aktiengesellschaft is a global consumer goods company headquartered in Hamburg, Germany, with a history dating back to its founding in 1882 by pharmacist Paul C. Beiersdorf. The company is best known for its skincare brands, including NIVEA, Eucerin, La Prairie and Labello, as well as its tesa division, which produces self-adhesive products and industrial tapes. Over its long history, Beiersdorf has built a reputation for innovation in dermatological research and product development, introducing pioneering formulations that span mass-market and premium segments.

The company’s operations are organized into two main business divisions.